Top Markets
Coin of the day
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc.

GYRE
Xếp hạng trong cổ phiếu #11143
Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering,... Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other conditions, including dermatomyositis and interstitial lung disease linked to systemic sclerosis, pneumoconiosis, and diabetic kidney disease. The company's pipeline further includes F351 (Hydronidone), a compound structurally related to ETUARY. F351 is currently in Phase 3 studies for chronic hepatitis B-induced liver fibrosis and is in Phase 1 trials for liver fibrosis associated with nonalcoholic associated steatohepatitis (NASH). Other programs in development feature F573, which is progressing through Phase 2 studies for acute and acute-on-chronic liver failure. Additionally, two early-stage candidates, F528 and F230, are in preclinical development, focusing on chronic obstructive pulmonary disease (COPD) and pulmonary arterial hypertension (PAH), respectively. Established in 2002, Gyre Therapeutics, Inc. is based in San Diego, California, and operates as a subsidiary of GNI USA, Inc.
Giá cổ phiếu
$6.61
Đồng bộ lần cuối: 2026-08-28
Vốn hóa thị trường
$736.94M
Thay đổi (1 ngày)
-1.05%
Thay đổi (1 năm)
-14.60%
Quốc gia
US
Giao dịch Gyre Therapeutics, Inc. (GYRE)

Danh mục

Lịch sử giá cổ phiếu của Gyre Therapeutics, Inc. (GYRE)
Giá đóng cửa cao nhất: $6.72 vào 2026-08-01

Giá đóng cửa thấp nhất: $12.50K vào 2006-04-01
Lịch sử giá cổ phiếu của Gyre Therapeutics, Inc. từ 2006 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -3.27%
2025 -32.25%
2024 -52.32%
2023 202.08%
2022 -50.65%
2021 -83.58%
2020 8.07%
2019 -33.68%
2018 -12.06%
2017 -1.82%
2016 -72.82%
2015 -85.70%
2014 -47.12%
2013 3.59%
2012 -31.84%
2011 -72.71%
2010 10.88%
2009 733.78%
2008 -69.18%
2007 13.36%
2006 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH